Embozene™ and Tandem™ are now sold by Varian.
Hypervascular Tumour Management
Boston Scientific has invested in the latest generation tightly calibrated microspheres that allow predictable and complete occlusion for consistent and reliable treatment in a variety of conditions.
Our commitment is to advance innovative therapies as well as clinical research , helping define how to better use the technologies and making a difference in the lives of patients.
For improved liver tumour response, TANDEM™ Microspheres are the only precisely calibrated microspheres which include small size options that enable to go deeper and deliver more drug into the tumour to support maximum tumour necrosis.
For a predictable, consistent embolisation, EMBOZENE Microspheres provide a broad range of colored, precisely calibrated microspheres in prefilled syringes that enable controlled delivery and reduce potential catheter occlusion